Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by A. Child
Pcn303 - Assessing the Value of Novel Immuno-Oncology (I-O) Therapies: How Consistent Is the Health Technology Assessment (Hta) Bodies' Consideration of the Survival Benefit in the Absence of Long-Term Data?
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Related publications
Pcn26 - Assessing the Potential Value of an Innovative Oncology Therapy From the Health Technology Assessment (Hta) Perspective: Marrying Clinical Value Frameworks With Economic Assessment Methodology
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Relative Value Assessment: Characterizing the Benefit of Oncology Therapies Through Diverse Survival Metrics From a US Perspective
ClinicoEconomics and Outcomes Research
Health Policy
Economics
Econometrics
Finance
Prm148 - Health Technology Assessment Agency Appraisal of Immuno-Oncology Cure Fraction Survival Modelling
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Prm109 - Exploring the Use and Acceptance of Alternative Survival Modelling Approaches for Immuno-Oncology Therapies in Uk Technology Assessments
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Prm64 - The Need for Innovative Survival Modelling Approaches in Health Technology Assessments (Hta) of Early-Stage Oncology Indications
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
The Role of Radiation Oncology in Immuno‐Oncology
Oncologist
Cancer Research
Medicine
Oncology
Assessing the Long-Term Safety of Endovascular Therapies—The Case of Peripheral Paclitaxel-Coated Devices
JAMA Cardiology
Cardiovascular Medicine
Cardiology
Long-Term Value in a Short-Term Market: How Exchange Business Turnover Is Impacting the Pharmaceutical Value Equation
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
How to Anticipate the Assessment of the Public Health Benefit of New Medicines?
Therapie
Pharmacology
